Magnetic seizure therapy and electroconvulsive therapy increase aperiodic activity

Area of Science:

• Neuroscience
• Psychiatry
• Computational Neuroscience

Background:

• Major depressive disorder (MDD) is a significant global health burden.
• Electroconvulsive therapy (ECT) is effective for treatment-resistant MDD, but its neural mechanisms remain unclear.
• Magnetic seizure therapy (MST) offers a potentially safer alternative to ECT, yet its underlying neural basis is also unknown.

Approach:

• Investigated changes in electroencephalogram (EEG) aperiodic activity in patients undergoing ECT or MST.
• Analyzed EEG data to quantify alterations in neural inhibition patterns post-treatment.
• Correlated changes in aperiodic activity with clinical outcomes and neural inhibition.

Key Points:

• Both ECT and MST treatments led to a significant increase in EEG aperiodic activity.
• Increased aperiodic activity was associated with greater neural inhibition.
• Aperiodic activity, not delta oscillations, explains clinical "slowing" observed after ECT and MST.

Conclusions:

• Aperiodic neural activity may represent a shared underlying mechanism of action for both ECT and MST.
• Understanding these neural mechanisms could lead to more targeted and effective treatments for depression.
• Further research is needed to fully elucidate the role of neural inhibition in the therapeutic effects of neuromodulation techniques.